Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2020-A00763-36 | Other Identifier | ID-RCB number,ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Coronavirus 2019 (COVID-19) is a respiratory tropism virus transmitted through droplets emitted into the environment of infected persons. The symptoms can be extremely varied and the course can range from spontaneous healing without sequelae to death.
Currently, the diagnosis of certainty for resuscitation patients (by definition "severe") is based on searching for a fragment of virus genetic material within the epithelial cells of the respiratory tree, up and/or down, by PCR.
It is to be expected that the epidemic peak will make it difficult (if not impossible) to respect the stereotypical path that is currently in place, due to the lack of space in the specific unit. This will require optimization of care pathways and use of the specific sectors.
It is therefore necessary to define the simple criteria, available from the moment patients are admitted, to predict the result of the COVID-19 PCR.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| patients suspected of infection with COVID-19. | Patients included with positive PCR and patients with negative PCR included |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between nasal and deep PCR positivity for Covid-19 patients performed and all predictors for Covid-19 patients performed within 24 hours of admission to ICU | within 24 hours of admission to ICU |
| Measure | Description | Time Frame |
|---|---|---|
| Coinfections | Assessment of viral, bacterial, fungal and parasitic rate in confirmed and unconfirmed patients for COVID-19 | during ICU stay, up to 28 days |
| Respiratory dysfunction requiring mechanical ventilation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The selection of patients will be carried out by a Doctor of Medicine practising within the ICU Lille Hospital taking care of patients suspected of infection with COVID-19.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Julien Poissy, MD,PhD | University Hospital, Lille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Roger Salengro, ICU, CHU Lille | Lille | 59037 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41093046 | Derived | Ledoult E, Guerrier T, Dubucquoi S, Figeac M, Villenet C, Daunou B, Behal H, Pokeerbux MR, Machet T, Koether V, Collet A, Launay D; Lille Covid Research network (LICORNE). Dual role of plasmablasts as immune regulators or amplifiers in COVID-19. Clin Immunol. 2025 Dec;281:110609. doi: 10.1016/j.clim.2025.110609. Epub 2025 Oct 13. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D011014 | Pneumonia |
| ID | Term |
|---|---|
| D007239 | Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
it will be reported the evolution of respiratory dysfunction in patients infected with COVID-19 admitted to ICU during their stay and requiring mechanical ventilation (during, Pao2/FIO2 ratio,,features of artificial ventilation features of extra-bodied respiratory assistance)
| during ICU stay, up to 28 days |
| Sequential Organ Failure Assessment (SOFA) Score | the SOFA assessment is used to track a person's risk status during stay in the Intensive Care Unit (ICU). The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal, and neurological systems. Each organ system is assigned a point value from 0 (normal) to 4 (high degree of dysfunction/failure). | during ICU stay, up to 28 days |
| SAPS II score | APS II was designed to measure the severity of disease for patients admitted to Intensive care units 24 hours after admission to the ICU, the measurement has been completed and resulted in an integer point score between 0 and 163 and a predicted mortality between 0% and 100%. | at admission |
| Disseminated Intravascular Coagulation (DIC) score | The DIC Score was developed by the The International Society of Thrombosis and Haemostasis (ISTH.) The DIC score calculator accounts of the following four parameters.Each of the four parameters evaluated above have values that are weighted with a number of points varying from 0 to 3. By summing the points given to the choices, a final result between 0 and 8 is obtained | during ICU stay, up to 28 days |
| Number of days on vasopressive amines | during ICU stay, up to 28 days |
| Occurrence of an event of venous or arterial thromboembolic disease | during ICU stay, up to 28 days |
| Number of days with extra renal treatment (ERA) | during ICU stay, up to 28 days |
| Number of patients alive after ICU stay less than 28 days will be tracked | At 28 day |
| Short Form 36 | measuring the long-term impact of confirmed COVID-19 infection. assessment of quality of life according to 8 areas: physical activity (and related limitations), body pain, perception of one's own health, mental health (and related limitations), social life and vitality. | at 9 months +/- 3 months after ICU stay |
| Hospital anxiety and depression scale (HADS) | The scale allows to detect anxiety and depression using 14 items rated from 0-3. Measuring the long-term impact of confirmed COVID-19 infection | at 9 months +/- 3 months after ICU stay |
| Impact of Event Scale - revised (IES-R) | 22-item self-report measure that assesses subjective distress caused by traumatic events Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The IES-R yields a total score (ranging from 0 to 88) Measuring the long-term impact of confirmed COVID-19 infection | at 9 months +/- 3 months after ICU stay |
| Post-traumatic stress disorder Checklist version DSM-5 (PSL-5) | Question the stressful experience or event, followed by 20 multiple-choice questions. Measuring the long-term impact of confirmed COVID-19 infection | at 9 months +/- 3 months after ICU stay |
| Modified Medical Research Council (MMRC) Dyspnea Scale | The mMRC Dyspnea Scale stratifies severity of dyspnea in respiratory diseases Measuring the long-term impact of confirmed COVID-19 infection | at 9 months +/- 3 months after ICU stay |
| Correlation between number of patient deaths and all predictors for Covid-19 including anamnestic, clinical, biological, radiological parameters | until day 28 after admission of ICU |
| Viral clearance | Evolution of viral clearance in nasal and depp PCR during ICU | through study completion, an average of 28 days |
| D012141 |
| Respiratory Tract Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |